Aytu BioPharma (0A8M.LSE) Q1 2025 Earnings

12FebConfirmed
Q2 2024
Q3 2024
Q4 2024
Q1 2025
-0.82
-0.61
-0.41
-0.2

Details

Expected EPS
-0.28
Actual EPS
-0.28
Surprise EPS
0
Surprise Percent
+0%

Description

Aytu BioPharma (0A8M.LSE) has reported earnings of -0.28 per share for Q1 2025.

0 Comments

Share your thoughts